Scheduled for June 13, 2016, in Boston, Massachusetts, Axiogenesis is hosting an American symposium titled, “iPSC Derived Cells & Assays Come of Age.” Hosted at the Westin Waterfront, the symposium will explore how experts in the pharmaceutical industry and leading academic institutions are using Axiogenesis’ cells and assays in drug discovery, safety/toxicology screening, and bioengineering. It will also present current approaches to establish and define standards for these cellular models.
Expected to be widely attended by representatives from the pharmaceutical sector, symposium attendees will also view case studies of iPS cells in drug development decision-making and biomedical research. [Read more…]